Overview
- 39 inspections across 36 sites are on record.
- 177 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-08.
At a glance
Inspections
39
Sites
36
Observations
177
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Armstrong Pharmaceuticals, Inc. | 8 May 2026 | Human Drugs | On file |
| Lantheus Medical Imaging, Inc. | 9 Apr 2026 | Human Drugs | On file |
| Tropical Seas, Inc. | 12 Feb 2026 | Human Drugs | On file |
| Shire Human Genetic Therapies, Inc. | 18 Dec 2025 | Human Drugs | On file |
| Fresenius Kabi Compounding, LLC | 5 Nov 2025 | Human Drugs | View 483 → |
Sites inspected
Armstrong Pharmaceuticals, Inc.Canton, United States1 insp.
Lantheus Medical Imaging, Inc.North Billerica, United States1 insp.
Tropical Seas, Inc.Holly Hill, United States1 insp.
Shire Human Genetic Therapies, Inc.Lexington, United States1 insp.
Fresenius Kabi Compounding, LLCCanton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sean R Marcsisin12 shared
Daniel L Zheng7 shared
Edmund F Mrak5 shared
Ifechimere I Okafor2 shared
Paige R Mccoy2 shared
Armen H Youssoufian2 shared
Jessica S Estriplet1 shared
Jonathan G Matrisciano1 shared
Bijoy Panicker1 shared
Margaret M Doherty1 shared
Full investigator report
Get the verbatim findings behind Lori M Newman's 177 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site